ResearcherChina Pharmaceutical UniversityNo recent work listed

Xiaoxiao Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-9577-0459; OpenAlex author ID A5100339084. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Co-author DOI 10.1007/s11427-019-1753-3 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pyone Myat Thu · 1 shared paper, 2021 · strength 0.14
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3 ↗
Ji Li · 1 shared paper, 2021 · strength 0.14
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3 ↗
Ping Li · 1 shared paper, 2021 · strength 0.14
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3 ↗
Peng Yang · 1 shared paper, 2021 · strength 0.14
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3 ↗
Xiaojun Xu · 1 shared paper, 2021 · strength 0.14
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.